These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 309193)

  • 1. International committee communications. Registry of prospective clinical trials. Third report.
    Verstraete M
    Thromb Haemost; 1978 Jun; 39(3):759-67. PubMed ID: 309193
    [No Abstract]   [Full Text] [Related]  

  • 2. ICTH(International Committee on Haemostasis and Thrombosis)--Sub committee on Clinical Trials. Registry of Multicenter Clinical Trials. Seventh Report--1985.
    Boissel JP
    Thromb Haemost; 1986 Apr; 55(2):282-91. PubMed ID: 3487136
    [No Abstract]   [Full Text] [Related]  

  • 3. Which patients with coronary artery disease are most prone to develop a coronary artery event (presumably thrombosis)?
    Prentice CR
    Thromb Haemost; 1979 Feb; 41(1):63-72. PubMed ID: 384588
    [No Abstract]   [Full Text] [Related]  

  • 4. Registry of Prospective Clinical Trials--Sixth Report.
    Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):283-90. PubMed ID: 6377569
    [No Abstract]   [Full Text] [Related]  

  • 5. International Committee Communications. ICTH (International Committee on Thrombosis and Haemostasis). Subcommittee on Clinical Trials: Registry of Multicenter Clinical Trials. Eighth report 1986.
    Boissel JP
    Thromb Haemost; 1987 Jun; 57(3):361-71. PubMed ID: 3660335
    [No Abstract]   [Full Text] [Related]  

  • 6. Registry of prospective clinical trials--fifth report.
    Verstraete M
    Thromb Haemost; 1982 Dec; 48(3):334-8. PubMed ID: 6761891
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 8. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis of coronary artery disease.
    Kostis JB
    Am Fam Physician; 1979 Dec; 20(6):112-7. PubMed ID: 316280
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the protective effect of previous coronary artery bypass graft compared with percutaneous transluminal coronary angioplasty in patients with diabetes who suffer an acute myocardial infarction?
    Dunlap J
    J Fam Pract; 2000 Jul; 49(7):599-600. PubMed ID: 10923566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
    Breddin K
    Z Gesamte Inn Med; 1984 May; 39(10):234-41. PubMed ID: 6380127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antithrombotic drugs in artery disease.
    Gallus AS
    Clin Haematol; 1986 May; 15(2):509-59. PubMed ID: 3524934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis, a review.
    Rhoads JP
    J Okla State Med Assoc; 1972 Mar; 65(3):89-94. PubMed ID: 5025491
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC
    Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of basic therapy of ischemic heart disease on vascular-platelet hemostasis during myocardial revascularization].
    Vorob'eva NA; Nedashkovskiĭ EV
    Anesteziol Reanimatol; 2001; (3):47-50. PubMed ID: 11510359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants updated--application in coronary artery disease.
    Robinson DS
    Cardiovasc Clin; 1974; 6(2):9-22. PubMed ID: 4613466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.